# Patient Square Capital LP: Form 13F holdings

An institutional investment manager in MENLO PARK, CA. SEC CIK 1819257.

- Quarter ended: 2026-06-30
- Filed: 2026-08-12
- Reported value: $645.5m
- Positions: 23 (23 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1819257/000181925726000005/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| ROIVANT SCIENCES LTD | SHS | $283.9m | 44.0% | 8,020,928 |  | Reduced −145,119 |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $51.7m | 8.0% | 276,000 |  | New +276,000 |
| [MIRUM PHARMACEUTICALS INC (MIRM)](/companies/mirm.md) | COM | $30.5m | 4.7% | 260,500 |  | Added +30,500 |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $27.5m | 4.3% | 206,500 |  | Added +85,255 |
| [BEONE MEDICINES LTD (ONC)](/companies/onc.md) | SPONSORED ADS | $25.7m | 4.0% | 90,020 |  | Added +9,478 |
| PHARVARIS N V | COM | $23.2m | 3.6% | 671,209 |  | Added +178,209 |
| [ARGENX SE (ARGX)](/companies/argx.md) | SPONSORED ADR | $21.3m | 3.3% | 23,000 |  | Reduced −13,718 |
| [UNITED THERAPEUTICS CORP DEL (UTHR)](/companies/uthr.md) | COM | $20.1m | 3.1% | 37,120 |  | New +37,120 |
| [BELITE BIO INC (BLTE)](/companies/blte.md) | SPONSORED ADS | $16.9m | 2.6% | 110,000 |  | Reduced −6,684 |
| [COGENT BIOSCIENCES INC (COGT)](/companies/cogt.md) | COM | $16.4m | 2.5% | 425,000 |  | Reduced −171,000 |
| [DBV TECHNOLOGIES S A (DBVT)](/companies/dbvt.md) | SPONSORED ADS | $14.9m | 2.3% | 909,474 |  | Added +215,940 |
| [XENON PHARMACEUTICALS INC (XENE)](/companies/xene.md) | COM | $13.3m | 2.1% | 220,000 |  | Reduced −7,000 |
| [BIONTECH SE (BNTX)](/companies/bntx.md) | SPONSORED ADS | $12.5m | 1.9% | 134,429 |  | New +134,429 |
| [ARCUS BIOSCIENCES INC (RCUS)](/companies/rcus.md) | COM | $11.0m | 1.7% | 355,800 |  | Added +160,800 |
| [ENLIVEN THERAPEUTICS INC (ELVN)](/companies/elvn.md) | COM | $10.8m | 1.7% | 212,500 |  | Added +12,500 |
| [DIANTHUS THERAPEUTICS INC (DNTH)](/companies/dnth.md) | COM | $10.5m | 1.6% | 108,000 |  | Added +14,118 |
| [ALLOGENE THERAPEUTICS INC (ALLO)](/companies/allo.md) | COM | $10.5m | 1.6% | 5,050,000 |  | Added +1,600,000 |
| [EYEPOINT INC (EYPT)](/companies/eypt.md) | COM NEW | $10.3m | 1.6% | 720,000 |  | Reduced −75,000 |
| [ARCUTIS BIOTHERAPEUTICS INC (ARQT)](/companies/arqt.md) | COM | $9.7m | 1.5% | 370,000 |  | Reduced −30,645 |
| [C4 THERAPEUTICS INC (CCCC)](/companies/cccc.md) | COM STK | $7.5m | 1.2% | 1,608,815 |  | New +1,608,815 |
| [INVENTIVA SA (IVA)](/companies/iva.md) | ADS | $7.4m | 1.2% | 1,967,171 |  | New +1,967,171 |
| [KYMERA THERAPEUTICS INC (KYMR)](/companies/kymr.md) | COM | $5.4m | 0.8% | 47,500 |  | Reduced −52,500 |
| [FAETH THERAPEUTICS INC (FTH)](/companies/fth.md) | COM NEW | $4.4m | 0.7% | 175,050 |  | New +175,050 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ASSEMBLY BIOSCIENCES INC (ASMB)](/companies/asmb.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −136,315 |
| [CELCUITY INC (CELC)](/companies/celc.md) | COM | $0 | 0.0% | 0 |  | Sold out −95,000 |
| [CYTOMX THERAPEUTICS INC. (CTMX)](/companies/ctmx.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,085,790 |
| [DEFINIUM THERAPEUTICS INC (DFTX)](/companies/dftx.md) | COM SHS | $0 | 0.0% | 0 |  | Sold out −331,000 |
| [HARROW INC (HROW)](/companies/hrow.md) | COM | $0 | 0.0% | 0 |  | Sold out −165,209 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $0 | 0.0% | 0 |  | Sold out −157,500 |
| [LEGEND BIOTECH CORP (LEGN)](/companies/legn.md) | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −990,000 |
| [MERCK & CO INC (MRK)](/companies/mrk.md) | COM | $0 | 0.0% | 0 |  | Sold out −80,000 |
| [NEKTAR THERAPEUTICS (NKTR)](/companies/nktr.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −210,000 |
| [PERSPECTIVE THERAPEUTICS INC (CATX)](/companies/catx.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −1,625,000 |
| [PROTARA THERAPEUTICS INC (TARA)](/companies/tara.md) | COM STK | $0 | 0.0% | 0 |  | Sold out −1,030,846 |
| [SPYRE THERAPEUTICS INC (SYRE)](/companies/syre.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −1,000 |

Source: SEC EDGAR, Form 13F-HR, accession 0001819257-26-000005. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.